Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

DRUG(2)

Obeticholic Acid (OCA)

2 trials

phase_2phase_3

intercept-pharmaceuticals

1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Phase 31

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT00570765Phase 2Completed

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

Liver Cirrhosis, Biliary

StudychairStart date: 2008-01-17

NCT01473524Phase 3Completed

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

Studychair

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Liver Cirrhosis, Biliary1 Primary Biliary Cholangitis1

Affiliations

Intercept Pharmaceuticals, Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

E.J.L (Jenny) Heathcote, MD

UHN - Toronto Western Hospital, University of Toronto

Moderately Similar

5 trials

Shared therapeutic areas:

Liver Cirrhosis, BiliaryPrimary Biliary Cholangitis

Similarity Score30%

Rong Deng

Cascade Pharmaceuticals, Inc

3 trials

Shared therapeutic areas:

Primary Biliary Cholangitis

Similarity Score15%

Jason Sluzevich, MD

Mayo Clinic

3 trials

Shared therapeutic areas:

Primary Biliary Cholangitis

Similarity Score15%

Andrew L Mason, MBBS MRCPI

University of Alberta

1 trials

Shared therapeutic areas:

Primary Biliary Cholangitis

Similarity Score15%

Keith Lindor, MD

Mayo Clinic Foundation

1 trials

Shared therapeutic areas:

Primary Biliary Cholangitis

Similarity Score15%

jian wu, Doctor

The First Affiliated Hospital of Soochow University

2 trials

Shared therapeutic areas:

Primary Biliary Cholangitis

Similarity Score15%

Andrew Mason, MD

University of Alberta

2 trials

Shared therapeutic areas:

Primary Biliary Cholangitis

Similarity Score15%

Fu-Sheng Wang, professor

Beijing 302 Hospital

7 trials

Shared therapeutic areas:

Primary Biliary Cholangitis

Similarity Score15%

Aldo Torre Delgadillo, M.D. M.Sc

INCMNSZ

5 trials

Shared therapeutic areas:

Primary Biliary Cholangitis

Similarity Score15%

Fengchun Zhang, MD

Peking Union Medical College Hospital

3 trials

Shared therapeutic areas:

Primary Biliary Cholangitis

Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00570765Phase 2StudyChair

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

Liver Cirrhosis, Biliary

Completed

NCT01473524Phase 3StudyChair

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

Completed

All 2 trials loaded